Goto K, Ishikawa S, Honma R, Tanimoto K, Sakamoto N, Sentani K, Oue N, Teishima J, Matsubara A, Yasui W
Department of Molecular Pathology, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.
Department of Urology, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.
Oncogene. 2016 Jul 7;35(27):3598-606. doi: 10.1038/onc.2015.445. Epub 2015 Dec 7.
The transcribed-ultraconserved regions (T-UCRs) are a novel class of non-coding RNAs, which are absolutely conserved (100%) between the orthologous regions of the human, rat and mouse genomes. Previous studies have described that several T-UCRs show differential expressions in cancers and might be involved in cancer development. We investigated the transcriptional levels of representative 26 T-UCRs and determined the regions that were differently expressed in prostate cancer (PCa) and gastric cancer (GC). A quantitative reverse transcription-polymerase chain reaction analysis revealed the downregulation of Uc.158+A expression by a DNA methylation-associated mechanism, which was restored by 5-Aza-dC (5-aza-2'-deoxycytidine) treatment. Bisulfite genomic sequencing using cell lines and tissue samples demonstrated cancer-specific CpG hypermethylation in both GC and PCa. However, Uc.416+A was only overexpressed in GC and we identified an miR-153 binding site in the possible regulatory region of Uc.416+A using online databases. Along with a forced expression or knockdown of miR-153 in MKN-74 GC cells, the transcriptional levels of Uc.416+A were significantly disturbed. A luciferase reporter gene assay supported the direct regulation of Uc.416+A expression by miR-153. Furthermore, Uc.416+A was associated with cell growth through the regulation of IGFBP6 (insulin-like growth factor-binding protein 6) in GC. These findings suggest an oncogenic role of Uc.416+A in GC, which suggests that our approach would provide new insights into functional studies of T-UCRs in cancer biology.
转录超保守区域(T-UCRs)是一类新型的非编码RNA,在人类、大鼠和小鼠基因组的直系同源区域之间具有绝对保守性(100%)。先前的研究表明,几种T-UCRs在癌症中呈现差异表达,可能参与癌症的发生发展。我们研究了26种代表性T-UCRs的转录水平,并确定了在前列腺癌(PCa)和胃癌(GC)中差异表达的区域。定量逆转录-聚合酶链反应分析显示,Uc.158+A的表达通过DNA甲基化相关机制下调,5-氮杂-2'-脱氧胞苷(5-Aza-dC)处理可使其恢复。使用细胞系和组织样本的亚硫酸氢盐基因组测序表明,GC和PCa中均存在癌症特异性的CpG高甲基化。然而,Uc.416+A仅在GC中过表达,我们使用在线数据库在Uc.416+A的可能调控区域中鉴定出一个miR-153结合位点。在MKN-74 GC细胞中强制表达或敲低miR-153后,Uc.416+A的转录水平受到显著干扰。荧光素酶报告基因测定支持miR-153对Uc.416+A表达的直接调控。此外,在GC中,Uc.416+A通过调节胰岛素样生长因子结合蛋白6(IGFBP6)与细胞生长相关。这些发现表明Uc.416+A在GC中具有致癌作用,这表明我们的方法将为癌症生物学中T-UCRs的功能研究提供新见解。